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Tn this issue of the Journal, Ballaux and colleagues1 from The Netherland
present their experience with more than 200 patients who underwent the
cut-and-sew maze III procedure. The study was designed to assess the long-term
esults of the maze III procedure.
In recent years we have witnessed a significant increase in the number of surgical
rocedures performed to ablate atrial fibrillation. As a result, there is a flux of
ublications reporting the results of such procedures. However, most of the studies
o not address the true impact of the procedure on patients’ outcome and well-being.
he literature is also lacking information regarding the correlation between the
uccess in ablating atrial fibrillation and a favorable long-term outcome.
The authors of this article are to be congratulated for their excellent results in a
arge series of patients. Nevertheless, the current report brings to attention the
ifficulties and challenges that we currently experience when assessing the results of
urgical treatment for atrial fibrillation and its impact on patient outcomes.
Although atrial fibrillation is considered by many to be an innocuous arrhythmia,
t may be associated with significant mortality and morbidity. The main focus is
bviously the risk of thromboembolic events and strokes; however, heart failure
ay develop in a significant number of patients. There is also growing evidence that
trial fibrillation can cause patients discomfort and anxiety with a negative impact
n quality of life.2 Therefore, the nonpharmacologic treatment to be offered
atients at risk for a complicated course is reasonable.3
efinition of the Surgical Treatment for Atrial Fibrillation
he first maze procedure was performed on September 25, 1987, only after exten-
ive laboratory work. The maze I procedure,4 the original surgical technique for t
reatment of atrial fibrillation, was modified to become the maze II procedure and
ater the maze III procedure because of late chronotropic problems with the sinoatrial
ode and intra-atrial conduction. The lesions of the maze procedure are well defined,
nd except for the septal incision, all of them were found to be important in achieving
uccess in restoring sinus rhythm. Although successful, the maze procedure never
ained popularity among cardiac surgeons and cardiologists mainly because of its
omplexity.
In 1998, Haissaguerre and colleagues5 published a key article in the New
ngland Journal of Medicine showing that the pulmonary veins are the source of the
ctopic beats leading to atrial fibrillation in most patients with paroxysmal atrial
brillation. These findings, combined with the relative complexity of the original
aze procedure and a number of new surgical ablation devices, led to a flux of new
urgical procedures, most of which, if not all, were referred to as the “modified maze
rocedure.”6
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LThe combination of the new surgical procedures and
blative devices using different energy sources led to a state
f confusion, because in almost every report a different type
f ablation device was used to apply a different lesion set.
The maze procedure should be executed exactly as was
escribed by Dr James L. Cox. If the procedure is not
erformed according to this description, then it should not
e referred to as the “maze procedure.” More so, the term
maze” should not be included to describe any of the
odifications to the maze procedure to avoid confusion. For
xample, pulmonary vein isolation should not be labeled as
he “modified maze procedure” or “mini-maze.”
In this issue the authors describe the surgical procedure
s the “unmodified maze procedure,” yet it is clearly stated
y the authors that a possible explanation for their results
eing inferior to those demonstrated by the group from
ashington University in St Louis may be because in their
eries they applied the cryolesion over the coronary sinus,
ot as originally described.4 The coronary sinus lesion 
mportant, and a failure to apply it the way it was designed
ay result in a higher failure rate than expected. This is a
ood example of why we should all be careful when assess-
ng the success of the maze procedure. We should be aware
f the differences between the maze procedure as described
y Dr Cox and other surgical ablation procedures that are
eing published.
Nevertheless, the authors’ statement regarding the need
or better understanding the differences between the various
rocedures and the surgical modifications is important, and
rospective randomized studies should be a unified goal.
oals of the Surgical Treatment for
trial Fibrillation
hen assessing the success of the surgical treatment for
trial fibrillation, the following variables are important:
1. Success in restoring sinus rhythm
2. Reduced risk of thromboembolic events
3. Improved quality of life
The definitions of success and failure of the surgical
reatment for atrial fibrillation are important. In general, we
ave yet to establish a set of follow-up guidelines to deal
ith the definition of success and failure (eg, valve surgery
nd coronary artery bypass graft surgery). Currently most of
he reports rely on patients’ perceptions regarding their
hythm and/or a single electrocardiogram strip. We all know
hat this is likely not sufficient, yet this is the reality of
urrent practice. To change the current practice, specific
uidelines of follow-up and definitions of success and fail-
re need to be established and published.
In this study the authors place a considerable amount of
mphasis on acquiring more data from the patients. As a
esult, we have much more information regarding the inci-
ence of postoperative arrhythmia. Nevertheless, there is a
ignificant difference in the method of follow-up for pa-
254 The Journal of Thoracic and Cardiovascular Surgery ● Decients who were followed by the surgeons or referring
hysicians.
An important question that we have yet to answer is
hether short bursts of atrial arrhythmia are clinically sig-
ificant and should be defined as a failure of the procedure.
he answer should be associated to the incidence of throm-
oembolic events and improved quality of life. This study
nd others show that the maze procedure is effective in
educing the risk of strokes.7 The success in reducing t
isk of strokes in the surgical population is important and
hus should be considered as one of the components of a
uccessful procedure. Unlike most of the patients under-
oing catheter ablation, the majority of patients who
nderwent surgery in this series and in others had at least
ne major risk factor for stroke when in atrial fibrillation.
Data regarding the improvement in quality of life are
acking. We need more prospective studies designed to
orrelate the success in ablating atrial fibrillation and quality
f life. One of the components of success of the surgical
rocedure is to improve quality of life. This can be accom-
lished even in patients who are in some sort of atrial
rrhythmia after an intervention and yet have improved
uality of life. Therefore it is important to establish a more
omprehensive arrhythmia and quality of life follow-up
rotocol to be able to prospectively link the success in
blating atrial fibrillation and improvements in patients’
utcome. Our recent protocol includes a longitudinal quality
f life assessment, using validated tools, of all patients
ndergoing surgery for atrial fibrillation.
onclusion
he surgical community should be specific when defining
he surgical procedure used to ablate atrial fibrillation. Most
f the medical community is not familiar with the fine
etails about the maze procedure and its modifications.
herefore, avoiding the terms “modified maze” and “mini-
aze” when describing a procedure is appropriate. The term
maze procedure” should only be used to describe the
rocedure as it was designed by Dr James L. Cox.4
There is a need to establish a standard of care for patients
fter surgery for atrial fibrillation. Clear follow-up guide-
ines should be published and followed. A better follow-up
ith increased awareness of patients’ arrhythmias and as-
ociated symptoms will result in adequate treatment and
mprovement in the long-term success of the procedure7
In general, the patients who present for surgical ablation
f atrial fibrillation pose a challenge, because the arrhythmia
s usually accompanied with an enlarged left atrium and
dvanced tissue remodeling. Thus, by using a limited lesion
et in these patients, a less favorable success rate should be
xpected.The appendix includes additional relevant references.
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